Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure

Department of Cardiac Medicine, Royal Brompton Hospital, London, England, United Kingdom.

OBJECTIVES: We sought to test the hypothesis that suppression of chemosensitivity (respiratory response to arterial blood gases) with dihydrocodeine may improve dyspnea and exercise tolerance in patients with chronic heart failure. BACKGROUND: Exertional dyspnea is a common limiting symptom in patients with chronic heart failure. The mechanisms underlying this symptom are not fully understood but may be related to increased ventilation caused, in part, by the augmentation of chemosensitivity. Suppression of chemosensitivity with mild opiates may thus improve this symptom as well as exercise tolerance. METHODS: Twelve men with chronic heart failure (mean [+/-SE] age 65.5 +/- 1.5 years, range 58 to 75; left ventricular ejection fraction 21.3 +/- 3.0%, range 8 to 39) received placebo or dihydrocodeine (1 mg/kg body weight) on two separate days in a randomized, double-blind design. One hour later, hypoxic and hypercapnic chemosensitivities were assessed using the transient inhalations of pure nitrogen and the rebreathing of 7% carbon dioxide in 93% oxygen, followed by treadmill cardiopulmonary exercise testing. The symptoms of dyspnea and fatigue during the exercise test were assessed using a modified Borg scale from 0 to 10. RESULTS: There was a significant fall in hypoxic and hypercapnic chemosensitivities with dihydrocodeine administration compared with placebo (0.447 +/- 0.096 vs. 0.746 +/- 0.104 liter/min per percent arterial oxygen saturation, p = 0.005; 2,480 +/- 0.234 vs. 2.966 +/- 0.283 liter/min per mm Hg, p = 0.01, respectively). Exercise duration was prolonged from 455 +/- 27 s on placebo to 512 +/- 27 s (p = 0.001) with dihydrocodeine, and peak oxygen consumption increased from 18.0 +/- 0.6 to 19.7 +/- 0.6 ml/kg per min (p = 0.002). The ventilatory response to exercise, characterized by the regression slope relating minute ventilation to carbon dioxide output, decreased from 34.19 +/- 2.35 to 30.85 +/- 1.91 (p = 0.01). With dihydrocodeine administration, the change in the modified Borg score for dyspnea was -0.80 (p = 0.003) at 6 min and -0.33 (p = 0.52) at peak exercise, whereas that for fatigue did not change significantly. Arterial oxygen saturation was maintained during exercise despite dihydrocodeine administration (99.3% at rest vs. 98.9% at peak exercise, p = 0.21). CONCLUSIONS: Augmented chemosensitivity is important in the pathophysiology of chronic heart failure. Its suppression with dihydrocodeine was associated with a reduction of exercise ventilation, an improvement in exercise tolerance and a decrease in breathlessness. Pharmacologic modulation of chemosensitivity may benefit patients with chronic heart failure and merits further investigation.

This article has been cited by other articles:

				R. B. Banzett, L. Adams, C. R. O'Donnell, S. A. Gilman, R. W. Lansing, and R. M. Schwartzstein Using Laboratory Models to Test Treatment: Morphine Reduces Dyspnea and Hypercapnic Ventilatory Response Am. J. Respir. Crit. Care Med., October 15, 2011; 184(8): 920 - 927. [Abstract] [Full Text] [PDF]

				S. G. Oxberry, D. J. Torgerson, J. M. Bland, A. L. Clark, J. G. F. Cleland, and M. J. Johnson Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial Eur J Heart Fail, September 1, 2011; 13(9): 1006 - 1012. [Abstract] [Full Text] [PDF]

				P. Agostoni and G. Cattadori Patterns of response diagnostic for cardiac disease Clinical Exercise Testing, June 10, 2010; 93 - 107. [Abstract] [Fulltext] [PDF]

				M. J. Johnson, S. G. Oxberry, J. G.F. Cleland, and A. L. Clark Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review Eur J Heart Fail, February 1, 2010; 12(2): 137 - 147. [Abstract] [Full Text] [PDF]

				S. J. Goodlin Palliative Care in Congestive Heart Failure J. Am. Coll. Cardiol., July 28, 2009; 54(5): 386 - 396. [Abstract] [Full Text] [PDF]

				A. Giannoni, M. Emdin, F. Bramanti, G. Iudice, D. P. Francis, A. Barsotti, M. Piepoli, and C. Passino Combined Increased Chemosensitivity to Hypoxia and Hypercapnia as a Prognosticator in Heart Failure J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1975 - 1980. [Abstract] [Full Text] [PDF]

				M. J Johnson Management of end stage cardiac failure Postgrad. Med. J., June 1, 2007; 83(980): 395 - 401. [Abstract] [Full Text] [PDF]

				P. Agostoni, M. Contini, A. Magini, A. Apostolo, G. Cattadori, M. Bussotti, F. Veglia, D. Andreini, and P. Palermo Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia Eur J Heart Fail, November 1, 2006; 8(7): 729 - 735. [Abstract] [Full Text] [PDF]

				M. Guazzi, G. Reina, G. Tumminello, and M. D. Guazzi Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients Eur J Heart Fail, October 1, 2005; 7(6): 1017 - 1022. [Abstract] [Full Text] [PDF]

				S. D. Rosen, K. Murphy, A. P. Leff, V. Cunningham, R. J.S. Wise, L. Adams, A. J.S. Coats, and P. G. Camici Is central nervous system processing altered in patients with heart failure? Eur. Heart J., June 1, 2004; 25(11): 952 - 962. [Abstract] [Full Text] [PDF]

				A. P Abernethy, D. C Currow, P. Frith, B. S Fazekas, A. McHugh, and C. Bui Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ, September 6, 2003; 327(7414): 523 - 528. [Abstract] [Full Text] [PDF]

				S G Williams, D J Wright, P Marshall, A Reese, B-H Tzeng, A J S Coats, and L-B Tan Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure Heart, September 1, 2003; 89(9): 1085 - 1086. [Full Text] [PDF]

				T Tomita, H Takaki, Y Hara, F Sakamaki, T Satoh, S Takagi, Y Yasumura, N Aihara, Y Goto, and K Sunagawa Attenuation of hypercapnic carbon dioxide chemosensitivity after postinfarction exercise training: possible contribution to the improvement in exercise hyperventilation Heart, April 1, 2003; 89(4): 404 - 410. [Abstract] [Full Text] [PDF]

				M.J. Johnson, T.A. McDonagh, A. Harkness, S.E. McKay, and H.J. Dargie Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study Eur J Heart Fail, December 1, 2002; 4(6): 753 - 756. [Abstract] [Full Text] [PDF]

				M F Muers Opioids for dyspnoea Thorax, November 1, 2002; 57(11): 922 - 923. [Full Text] [PDF]

				A-L Jennings, A N Davies, J P T Higgins, J S R Gibbs, and K E Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax, November 1, 2002; 57(11): 939 - 944. [Abstract] [Full Text] [PDF]

				P. Ponikowski, T. P. Chua, S. D. Anker, D. P. Francis, W. Doehner, W. Banasiak, P. A. Poole-Wilson, M. F. Piepoli, and A. J.S. Coats Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure Circulation, July 31, 2001; 104(5): 544 - 549. [Abstract] [Full Text] [PDF]

				P. Ponikowski, D. P. Francis, M. F. Piepoli, L. C. Davies, T. P. Chua, C. H. Davos, V. Florea, W. Banasiak, P. A. Poole-Wilson, A. J. S. Coats, et al. Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance : Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis Circulation, February 20, 2001; 103(7): 967 - 972. [Abstract] [Full Text] [PDF]

				R. S. Morrison, A. L. Siu, R. M. Leipzig, C. K. Cassel, and D. E. Meier The Hard Task of Improving the Quality of Care at the End of Life Arch Intern Med, March 27, 2000; 160(6): 743 - 747. [Full Text] [PDF]

				P. Ponikowski, S. D. Anker, T. P. Chua, D. Francis, W. Banasiak, P. A. Poole-Wilson, A. J. S. Coats, and M. Piepoli Oscillatory Breathing Patterns During Wakefulness in Patients With Chronic Heart Failure : Clinical Implications and Role of Augmented Peripheral Chemosensitivity Circulation, December 14, 1999; 100(24): 2418 - 2424. [Abstract] [Full Text] [PDF]

				J. M. Marin, M. Montes de Oca, J. Rassulo, and B. R. Celli Ventilatory Drive at Rest and Perception of Exertional Dyspnea in Severe COPD Chest, May 1, 1999; 115(5): 1293 - 1300. [Abstract] [Full Text] [PDF]